- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Faculty of Medicine in Pilsen
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Imatinib mesylate (Glivec) in treatment of chronic myeloid leukemia in chronic phase2004 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové
- The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients2018 | Faculty of Medicine in Hradec Králové
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Impact of age on the clinical response of patients with CML treated with imatinib2015 | Faculty of Medicine in Hradec Králové
- Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial2018 | Second Faculty of Medicine
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine